Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
NCT00718367 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2014-01-14
Summary
The objective of the study is to determine whether a specific immune microenvironment in the primary tumor is associated with a favorable clinical course after nephrectomy and in the absence of adjuvant treatment.
Conditions
Sponsors & Collaborators
-
National University Hospital, Singapore
lead OTHER
Principal Investigators
-
Alvin Seng Cheong Wong, MRCP, MB ChB · National University Hospital, Singapore
-
Sing Joo Chia · Tan Tock Seng Hospital
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Completion
- 2013-11-30
Countries
- Singapore
Study Locations
More Related Trials
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
PD-L1 Expression in Japanese Renal Cell Carcinoma Patients
NCT03748901 ·Status: COMPLETED
-
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
NCT05782400 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
NCT06773377 ·Status: NOT_YET_RECRUITING
-
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
NCT07118813 ·Status: RECRUITING
-
Optimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916 ·Status: RECRUITING
-
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma
NCT03156868 ·Status: COMPLETED
-
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344 ·Status: COMPLETED
-
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
NCT06656039 ·Status: COMPLETED
-
A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
NCT07060248 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
NCT06762470 ·Status: ACTIVE_NOT_RECRUITING
-
Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets
NCT01619501 ·Status: UNKNOWN
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer
NCT00943891 ·Status: UNKNOWN
-
Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC)
NCT05706883 ·Status: COMPLETED
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study
NCT06484127 ·Status: COMPLETED
-
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
NCT00716209 ·Status: UNKNOWN
-
A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like Carcinoma
NCT04614818 ·Status: UNKNOWN
-
Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma
NCT03938012 ·Status: UNKNOWN
-
10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma
NCT06366906 ·Status: COMPLETED
-
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787 ·Status: RECRUITING
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN